Depreciation, Depletion and Amortization in USD of Sunshine Biopharma Inc. from Q1 2015 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Sunshine Biopharma Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2015 to Q1 2025.
  • Sunshine Biopharma Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2025 was $64.8K, a 52% increase year-over-year.
  • Sunshine Biopharma Inc. annual Depreciation, Depletion and Amortization for 2024 was $224K, a 49.9% increase from 2023.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)

Sunshine Biopharma Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $64.8K +$22.2K +52% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q1 2024 $42.6K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q1 2016 $15.2K +$15.2K Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-09
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09

Sunshine Biopharma Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $224K +$74.4K +49.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-01
2023 $149K Jan 1, 2023 Dec 31, 2023 10-K 2025-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.